All Posts: cancer
-
Recognizing the Toll of Oral Damage From Graft-Versus-Host Disease After Stem Cell Transplant
A new state-of-the-science paper by a team of investigators including researchers from Georgetown University Medical Center concludes that too little has been done to understand and effectively treat chronic chronic graft-versus-host disease.
Category: News Release
-
Katie Couric is the Inaugural Speaker at Georgetown's Edward M. Kovach Cura Personalis Endowed Lecture
On Aug. 7, Georgetown Lombardi welcomed Katie Couric, an award-winning journalist and the co-founder of cancer advocacy nonprofit Stand Up To Cancer, for the inaugural Edward M. Kovach Cura Personalis Endowed Lecture.
Category: Lombardi Stories
-
Study Shows Why a Common Form of Immunotherapy Fails, and Suggests Solution
New research from a team led by Georgetown Lombardi’s Samir N. Khleif, MD, has uncovered a mechanism thought to explain why some cancers don’t respond to a widely used form of immunotherapy.
Category: News Release
-
Georgetown Technique Using Urine Suggests Individualized Bladder Cancer Treatment Possible
A research team, led by investigators from Georgetown University Medical Center and Fudan University in China, has devised a promising non-invasive and individualized technique for detecting and treating bladder cancer.
Category: News Release
-
Can Green Tea Prevent Liver Cancer?
Georgetown University basic science researcher and oncology professor Fung Lung Chung, PhD, and Associate Professor of Oncology Aiwu Ruth He, MD, PhD, are testing the power of an extract found in green tea to prevent cancer in cirrhotic livers.
Category: Lombardi Stories
-
Indoor Tanning May Be an Addiction Abetted by Both Genetic and Psychiatric Factors
A new study reported by researchers at Georgetown Lombardi sheds light on factors that may influence an addiction to indoor tanning in a subset of women.
Category: News Release
-
Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
A study by Georgetown Lombardi Comprehensive Cancer Center physicians indicates that cancer patients with HIV or viral hepatitis, along with African Americans, who have been underrepresented in or excluded from most clinical trials, benefit from immunotherapy for cancer treatment at the same rate as other patients.
Category: News Release
-
Significant ‘Knowledge Gap’ Exists in Use of Genetic Testing to Decide Cancer Treatment
A survey aimed at assessing how well community oncologists understand “molecular profiling” results from tumor specimens found that 69 percent of participants either said they don’t know the answers, or they responded incorrectly.
Category: News Release
-
Georgetown University’s Cancer Center Receives Coveted ‘Comprehensive Cancer Center’ Status from the National Cancer Institute
WASHINGTON (May 7, 2019) — The National Cancer Institute (NCI) has renewed Georgetown Lombardi Comprehensive Cancer Center’s designation as a “comprehensive cancer center,” a distinction first awarded to Georgetown Lombardi in 1974. Of the 1,500 cancer programs in the U.S., only 50 are NCI-designated comprehensive cancer centers and Georgetown Lombardi is the only such center in the Washington, D.C., area. The […]
Category: News Release
-
Walking Warriors Second Annual Walk Raises More Than 35,000 for Breast Cancer
The Walking Warriors Battling Breast Cancer’s second-annual walk on April 27 raised more than 35,000 for breast cancer research, community service and education programs at Georgetown Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories